News
With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.
Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the ...
What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.
8hon MSN
Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
19h
MarketBeat on MSNOzempic Boom: Hims & Eli Lilly Lead Healthcare Bets
Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making ...
Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 percent ...
With the cost of the weight-loss jab set to rise by up to 170 per cent, Jade Kay, who has already spent £2,400 on the drug, says she will take a second job waitressing if she has to ...
E rin* has been using weight loss jabs for over six months. Desperate to lose 20kg, the 33-year-old first turned to Mounjaro ...
When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
Eli Lilly shares fell ~27% after disappointing trial results for its oral weight-loss drug. Click here to read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results